Novo Holdings (Life Sciences Fund)

About Novo Holdings (Life Sciences Fund)

Novo Holdings (Life Sciences Fund) is a venture capital firm based in Denmark, focusing on Series A stage investments. The fund actively supports founders building innovative solutions in Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionDenmark

Funding StageSeries A

Industry Focus

Deep Tech

Saas

Investor Signals Profile

active

Sweet Spot

Life science or bio-sustainability founder, any stage, global

life science

bio-sustainability

healthcare

impact investing

long-term returns

Bullish Signals

DKK 694bn AUM, record 2025 returnsexternal

9.2% CER return despite market volatilityexternal

Offices in 7 global citiesexternal

$125M Series A co-lead, April 2026external

Active deals Q1–Q2 2026external

$50M growth deal, Route 92 Medicalwebsite

India healthcare expansion, Jan 2026website

8.6% 10-yr avg annual portfolio returnwebsite

KabaFusion exit closed Jan 2026website

DKK 20bn record total income 2025website

Contrarian Signals

Primarily foundation-backed, not pure VCexternal

Life science focus limits scopeexternal

Novo Group concentration riskexternal

2.3% portfolio return in 2025 vs 9.2% CERwebsite

Founder Do's

Focus on healthcare or bio-sustainability

Show long-term return potential

Demonstrate societal/planetary impact

Be open to all dev stages

Align with responsible investment values

Founder Don'ts

Pitch non-life-science, non-impact plays

Expect short-term exit pressure

Ignore ESG/sustainability angle

Key GPs & Partners

Kasim Kutay

CEO

impact-drivenlong-term thinkerdiversified allocator

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size$1800M

Saves0

Website

Key People

Kasim Kutay, Christoffer Søderberg

Kasim KutayCEO